ADMP RSI Chart
Last 7 days
-4.4%
Last 30 days
-44.7%
Last 90 days
-61.8%
Trailing 12 Months
137.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 5.1M | 5.1M | 3.6M | 0 |
2022 | 2.9M | 3.5M | 4.2M | 4.9M |
2021 | 6.9M | 4.2M | 4.1M | 2.2M |
2020 | 21.9M | 20.0M | 15.0M | 10.1M |
2019 | 16.8M | 18.7M | 20.7M | 22.1M |
2018 | 13.2M | 13.3M | 13.8M | 15.1M |
2017 | 8.1M | 9.8M | 11.4M | 13.1M |
2016 | 0 | 0 | 0 | 6.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 25, 2023 | versi jannine | acquired | - | - | 177,194 | - |
May 25, 2023 | versi ebrahim | acquired | - | - | 8,745 | ceo |
May 25, 2023 | versi ebrahim | acquired | - | - | 177,194 | ceo |
May 25, 2023 | desai meera j. | acquired | - | - | 3,138 | - |
May 25, 2022 | carlo dennis j phd | acquired | - | - | 250,000 | - |
Mar 18, 2022 | benedicto david c. | sold | -2,207 | 0.6128 | -3,603 | chief financial officer |
Mar 18, 2022 | moss ronald b. | sold | -4,948 | 0.6036 | -8,199 | chief medical officer |
Mar 18, 2022 | marguglio david j. | sold | -7,116 | 0.6001 | -11,859 | svp and chief business officer |
Mar 18, 2022 | carlo dennis j phd | sold | -6,286 | 0.5993 | -10,490 | president & ceo |
Dec 09, 2021 | marguglio david j. | gifted | - | - | -13,000 | svp of bus. dev & cbo |
Which funds bought or sold ADMP recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | Clear Point Advisors Inc. | unchanged | - | -34.00 | 3.00 | -% |
May 15, 2024 | MORGAN STANLEY | sold off | -100 | -935 | - | -% |
May 15, 2024 | BANK OF AMERICA CORP /DE/ | sold off | -100 | -392 | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | sold off | -100 | -45,642 | - | -% |
May 15, 2024 | TWO SIGMA SECURITIES, LLC | sold off | -100 | -12,647 | - | -% |
May 14, 2024 | OLD POINT TRUST & FINANCIAL SERVICES N A | new | - | 1.00 | 1.00 | -% |
May 14, 2024 | Winch Advisory Services, LLC | unchanged | - | -1.00 | - | -% |
May 14, 2024 | NewEdge Advisors, LLC | sold off | -100 | -27.00 | - | -% |
May 14, 2024 | NORTHERN TRUST CORP | sold off | -100 | -72,476 | - | -% |
May 13, 2024 | FMR LLC | sold off | -100 | -1.00 | - | -% |
Unveiling Adamis Pharmaceuticals Corporation's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Date Filed | Form Type | Document | |
---|---|---|---|
Adamis Pharmaceuticals Corporation News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | 30.5% | 9,062 | 6,945 | 1,453,000 | 2,150,682 | 1,505,683 | 39,847 | 1,154,514 | 957,238 | 759,962 | 1,275,474 | 1,393,097 | 679,791 | 868,077 | 3,926,342 | 4,663,210 | 5,540,223 | 5,902,975 | 5,764,899 | 4,905,772 | 4,153,907 | 3,832,935 |
Gross Profit | 7.1% | -329,426 | -354,449 | -335,066 | -331,107 | -141,902 | -649,331 | -309,068 | -2,854,373 | -805,960 | -520,769 | -452,140 | -1,941,478 | -546,009 | -757,493 | 976,166 | 1,341,403 | 1,914,013 | 2,099,334 | 1,280,303 | 1,113,908 | 1,532,503 |
S&GA Expenses | -37.6% | 2,517,161 | 4,033,083 | 4,782,086 | 3,150,788 | 2,508,176 | 4,205,934 | 3,382,696 | 2,896,558 | 4,794,485 | 4,934,491 | 3,518,052 | 7,771,335 | 3,308,686 | 5,653,092 | 6,054,371 | 4,965,657 | 5,300,107 | 7,000,339 | 8,021,464 | 6,576,571 | 6,534,745 |
R&D Expenses | - | - | - | 1,310,529 | 859,846 | 1,977,939 | 3,320,654 | 4,221,525 | 2,195,765 | 4,620,143 | 2,196,721 | 2,249,744 | 1,349,332 | 1,647,746 | 3,085,824 | 2,036,732 | 2,014,989 | 3,318,743 | 2,845,745 | 2,196,514 | 7,800,725 | 3,908,408 |
EBITDA Margin | -43.2% | -7.06 | -4.93 | -4.84 | -5.09 | -7.90 | -9.39 | -11.55 | -15.01 | -8.44 | -8.10 | -4.90 | -3.26 | -1.60 | -1.20 | - | - | - | - | - | - | - |
Interest Expenses | -36.4% | 29,465 | 46,312 | - | - | - | - | - | - | 1,865 | 2,900 | 1,884 | -33,152 | 1,722 | 32,925 | 38,287 | 54,361 | 21,935 | 22,954 | 24,008 | 25,010 | 30,653 |
Income Taxes | - | - | - | - | -1,625 | - | - | - | - | - | - | - | -8,900 | - | - | - | -1,045 | 105 | - | - | -377,990 | - |
Earnings Before Taxes | - | - | - | -9,014,608 | -3,400,989 | -4,271,209 | - | -10,189,754 | -7,811,910 | -5,168,406 | - | - | -11,869,093 | -10,001,983 | - | - | - | - | - | - | - | - |
EBT Margin | -41.3% | -7.24 | -5.12 | -5.09 | -5.40 | -8.26 | -9.80 | -12.06 | -15.67 | -8.72 | -8.50 | -5.22 | -3.54 | -1.83 | -1.37 | - | - | - | - | - | - | - |
Net Income | 83.8% | -1,388,046 | -8,574,122 | -8,942,907 | -3,327,536 | -4,398,901 | -8,397,221 | -10,354,615 | -8,774,186 | -12,361,048 | -9,313,730 | -15,379,234 | -17,858,809 | -11,361,198 | -12,924,713 | -7,246,369 | -3,890,126 | -6,999,751 | -7,735,587 | -8,887,305 | -12,810,757 | -8,875,283 |
Net Income Margin | -24.5% | -6.14 | -4.93 | -4.87 | -5.46 | -7.62 | -11.30 | -14.22 | -20.75 | -13.37 | -12.79 | -8.38 | -4.87 | -2.36 | -1.55 | - | - | - | - | - | - | - |
Free Cashflow | -40.5% | -3,737,240 | -2,660,028 | -1,639,032 | -1,613,537 | -7,705,834 | -10,248,888 | -7,012,664 | -6,900,825 | -9,915,818 | -17,249,854 | -4,942,249 | -5,381,080 | -5,929,796 | -5,526,706 | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 88.6% | 9.00 | 5.00 | 9.00 | 11.00 | 12.00 | 18.00 | 31.00 | 38.00 | 45.00 | 64.00 | 81.00 | 31.00 | 44.00 | 31.00 | 45.00 | 48.00 | 53.00 | 47.00 | 53.00 | 58.00 | 70.00 |
Current Assets | 128.1% | 8.00 | 3.00 | 8.00 | 9.00 | 10.00 | 15.00 | 28.00 | 35.00 | 42.00 | 46.00 | 63.00 | 13.00 | 17.00 | 12.00 | 15.00 | 14.00 | 18.00 | 12.00 | 17.00 | 26.00 | 38.00 |
Cash Equivalents | 940.8% | 7.00 | 1.00 | 3.00 | 1.00 | 2.00 | 9.00 | 18.00 | 23.00 | 29.00 | 40.00 | 58.00 | 7.00 | 12.00 | 8.00 | 11.00 | 9.00 | 12.00 | 4.00 | 9.00 | 19.00 | 32.00 |
Inventory | -0.2% | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 | 0.00 | - | 2.00 | 3.00 | 1.00 | 2.00 | 2.00 | 3.00 | 2.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
Net PPE | -5.9% | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 | 10.00 | 2.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 12.00 | 11.00 | 10.00 | 9.00 |
Goodwill | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 4.00 | 4.00 | 4.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 | 8.00 |
Liabilities | -14.3% | 14.00 | 16.00 | 19.00 | 12.00 | 9.00 | 11.00 | 15.00 | 12.00 | 11.00 | 17.00 | 25.00 | 27.00 | 23.00 | 20.00 | 14.00 | 15.00 | 13.00 | 13.00 | 13.00 | 12.00 | 12.00 |
Current Liabilities | -10.3% | 13.00 | 15.00 | 13.00 | 11.00 | 9.00 | 10.00 | 14.00 | 11.00 | 9.00 | 13.00 | 21.00 | 20.00 | 12.00 | 12.00 | 11.00 | 9.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 |
Shareholder's Equity | - | - | - | - | - | 3.00 | 7.00 | 16.00 | 26.00 | 34.00 | 47.00 | 55.00 | 6.00 | 20.00 | 20.00 | 31.00 | 33.00 | 40.00 | 34.00 | 40.00 | 47.00 | 58.00 |
Retained Earnings | -0.4% | -323 | -322 | -313 | -304 | -301 | -296 | -288 | -278 | -269 | -256 | -247 | -229 | -212 | -200 | -187 | -180 | -176 | -169 | -161 | -153 | -140 |
Additional Paid-In Capital | 2.6% | 318 | 310 | 304 | 304 | 304 | 304 | 304 | 304 | 304 | 304 | 303 | 233 | 233 | 221 | 219 | 214 | 217 | 203 | 202 | 200 | 198 |
Shares Outstanding | 261.8% | 10.00 | 3.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 1.00 | 1.00 | 1.00 | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 74.00 | - | - | - | 163 | - | - | - | 39.00 | - | - | - | 61.00 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | -45.5% | -3,737 | -2,568 | -1,547 | -1,522 | -7,498 | -9,894 | -6,985 | -6,673 | -9,766 | -16,808 | -4,536 | -5,411 | -6,109 | -5,140 | -4,239 | -2,938 | -4,257 | -4,416 | -8,273 | -12,275 | -7,981 |
Share Based Compensation | -185.6% | -44.69 | 52.00 | 69.00 | -325 | 76.00 | -464 | 372 | 551 | 153 | 1.00 | 880 | 1,214 | 829 | 292 | 1,219 | 2,210 | 9.00 | 882 | 1,978 | 3,194 | - |
Cashflow From Investing | 1178.0% | 1,767 | 138 | 842 | 155 | 779 | 1,017 | 1,533 | 1,165 | -34.63 | -441 | -406 | 18.00 | -53.91 | -636 | -274 | -301 | -361 | -538 | -1,665 | -364 | -1,900 |
Cashflow From Financing | 1061690.1% | 7,963 | 750* | 2,724 | - | - | - | - | -42.85 | -2,007 | -24.79 | 56,011 | -128 | 10,649 | 3,162 | 6,210 | -71.73 | 12,648 | -143 | -141 | -122 | 37,495 |
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||||
---|---|---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |||
Income Statement [Abstract] | ||||||
REVENUE, net | $ 6,945 | $ 39,847 | $ 1,459,945 | $ 1,194,361 | ||
COST OF GOODS SOLD | 361,394 | 689,178 | 2,149,461 | 2,152,760 | ||
Gross Loss | (354,449) | (649,331) | (689,516) | (958,399) | ||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES | 4,033,083 | 4,205,934 | 8,815,168 | 7,588,630 | ||
RESEARCH AND DEVELOPMENT | 376,957 | 3,320,654 | 1,687,486 | 7,542,179 | ||
ACQUIRED IN-PROCESS RESEARCH & DEVELOPMENT (IPR&D) | 6,539,675 | 6,539,675 | ||||
Loss from Operations | (11,304,164) | (8,175,919) | (17,731,845) | (16,089,208) | ||
OTHER INCOME (EXPENSE) | ||||||
Interest Income | 703 | 16,174 | 713 | 20,322 | ||
Interest Expense | (46,312) | (106,344) | ||||
Other Income/(Expense) | 463,018 | (257,832) | 410,017 | (697,832) | ||
Gain/(Loss) on PPP2 loan | 62,583 | (1,787,417) | ||||
Excess of March 2023 Warrant Fair Value over Offering Proceeds | (2,476,109) | |||||
Change in Fair Value of Warrants | 3,883,364 | 19,540 | 3,885,569 | 28,927 | ||
Total Other Income (Expense), net | 4,300,773 | (159,535) | 1,713,846 | (2,436,000) | ||
Net Loss from Continuing Operations | (7,003,391) | (8,335,454) | (16,017,999) | (18,525,208) | ||
DISCONTINUED OPERATIONS | ||||||
Net Loss from Discontinued Operations before Income Taxes | (1,570,731) | (61,767) | (1,499,030) | (226,628) | ||
Income Taxes - Discontinued Operations | ||||||
Net Loss from Discontinued Operations | (1,570,731) | (61,767) | (1,499,030) | (226,628) | ||
Net Loss Applicable to Common Stock | $ (8,574,122) | $ (8,397,221) | $ (17,517,029) | $ (18,751,836) | ||
Basic and Diluted Loss Per Share: | ||||||
Continuing Operations, Basic Loss Per Share | [1] | $ (2.79) | $ (3.89) | $ (6.81) | $ (8.66) | |
Continuing Operations, Diluted Loss Per Share | [1] | (2.79) | (3.89) | (6.81) | (8.66) | |
Discontinued Operations, Basic Loss Per Share | [1] | (0.61) | (0.03) | (0.63) | (0.11) | |
Discontinued Operations, Diluted Loss Per Share | [1] | (0.61) | (0.03) | (0.63) | (0.11) | |
Basic Loss Per Share | [1] | (3.40) | (3.92) | (7.44) | (8.77) | |
Diluted Loss Per Share | [1] | $ (3.40) | $ (3.92) | $ (7.44) | $ (8.77) | |
Basic Weighted Average Shares Outstanding | [1] | 2,569,400 | 2,140,224 | 2,378,006 | 2,138,816 | |
Diluted Weighted Average Shares Outstanding | [1] | 2,569,400 | 2,140,224 | 2,378,006 | 2,138,816 | |
|
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Jun. 30, 2023 | Dec. 31, 2022 | ||
---|---|---|---|---|
CURRENT ASSETS | ||||
Cash and Cash Equivalents (including $135,287 and $0 associated with variable interest entity at June 30, 2023 and December 31, 2022, respectively) | $ 640,254 | $ 1,081,364 | ||
Restricted Cash | 30,090 | 30,068 | ||
Accounts Receivable, net | 1,054,058 | |||
Receivable from Fagron | 18,971 | 30,951 | ||
Inventories | 664,358 | 1,238,778 | ||
Prepaid Expenses and Other Current Assets | 658,119 | 1,884,015 | ||
Current Assets of Discontinued Operations | 1,438,906 | 3,952,916 | ||
Total Current Assets | 3,450,698 | 9,272,150 | ||
LONG TERM ASSETS | ||||
Fixed Assets, net | 1,142,869 | 1,288,894 | ||
Right-of-Use Assets | 145,909 | 317,622 | ||
Other Non-Current Assets | 9,674 | 52,174 | ||
Total Assets | 4,749,150 | 10,930,840 | ||
CURRENT LIABILITIES | ||||
Accounts Payable | 11,365,931 | 7,937,493 | ||
Deferred Revenue, current portion (including $147,118 and $0 associated with variable interest entity at June 30, 2023 and December 31, 2022, respectively) | 174,897 | 27,779 | ||
Accrued Other Expenses | 2,200,716 | 1,510,053 | ||
Product Recall Liability | 175,190 | 305,806 | ||
Lease Liabilities, Current Portion | 157,246 | 342,562 | ||
Current Liabilities of Discontinued Operations | 933,246 | 1,272,173 | ||
Total Current Liabilities | 15,007,226 | 11,395,866 | ||
LONG TERM LIABILITIES | ||||
Deferred Revenue, net of current portion | 164,357 | 178,247 | ||
Warrant Liabilities, at fair value | 1,072,893 | 7,492 | ||
Total Liabilities | 16,244,476 | 11,581,605 | ||
MEZZANINE EQUITY | ||||
Convertible Preferred Stock - Par Value $0.0001; 10,000,000 Shares Authorized; Series C Preferred Stock 3,000 Shares Authorized, liquidation preference $110 per share; 3,000 Issued and Outstanding at June 30, 2023 and December 31, 2022, respectively | 330,000 | 157,303 | ||
STOCKHOLDERS’ DEFICIT | ||||
Convertible Preferred Stock - Par Value $0.0001; 10,000,000 Shares Authorized; Series E Preferred Stock 1,941.2 Shares Authorized, Issued and Outstanding at June 30, 2023 and no Shares Authorized, Issued and Outstanding at December 31, 2022 | ||||
Common Stock - Par Value $0.0001; 200,000,000 Shares Authorized; 2,797,865 and 2,150,051 Issued, 2,790,395 and 2,142,581 Outstanding at June 30, 2023 and December 31, 2022, respectively | [1] | 15,831 | 15,051 | |
Additional Paid-in Capital | 310,245,208 | 303,746,217 | ||
Accumulated Deficit | (322,081,115) | (304,564,086) | ||
Treasury Stock - 7,470 Shares, at cost | [1] | (5,250) | (5,250) | |
Total Stockholders’ Deficit | (11,825,326) | (808,068) | ||
Total Liabilities, Mezzanine Equity and Stockholders’ Deficit | $ 4,749,150 | $ 10,930,840 | ||
|